Literature DB >> 16330634

Suicidal ideation among children taking atomoxetine (Strattera).

Eric Wooltorton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16330634      PMCID： PMC1316159          DOI： 10.1503/cmaj.051474

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  Atomoxetine (strattera) for ADHD.

Authors: 
Journal:  Med Lett Drugs Ther       Date:  2003-02-03       Impact factor: 1.909

2.  Atomoxetine (Strattera) revisited.

Authors: 
Journal:  Med Lett Drugs Ther       Date:  2004-08-16       Impact factor: 1.909
  2 in total
  5 in total

1.  Metabolic profiling of norepinephrine reuptake inhibitor atomoxetine.

Authors:  Kevin R MacKenzie; Mingkun Zhao; Mercedes Barzi; Jin Wang; Karl-Dimiter Bissig; Mirjana Maletic-Savatic; Sung Yun Jung; Feng Li
Journal:  Eur J Pharm Sci       Date:  2020-07-23       Impact factor: 4.384

2.  Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008.

Authors:  Rachel Kornfield; Sydeaka Watson; Ashley S Higashi; Rena M Conti; Stacie B Dusetzina; Craig F Garfield; E Ray Dorsey; Haiden A Huskamp; G Caleb Alexander
Journal:  Psychiatr Serv       Date:  2013-04-01       Impact factor: 3.084

3.  Lobeline Effects on Cognitive Performance in Adult ADHD.

Authors:  Catherine A Martin; Paul A Nuzzo; John D Ranseen; Mark S Kleven; Greg Guenthner; Yolanda Williams; Sharon L Walsh; Linda P Dwoskin
Journal:  J Atten Disord       Date:  2013-08-21       Impact factor: 3.256

Review 4.  Current issues around the pharmacotherapy of ADHD in children and adults.

Authors:  Willemijn M Meijer; Adrianne Faber; Els van den Ban; Hilde Tobi
Journal:  Pharm World Sci       Date:  2009-06-27

Review 5.  The association of ADHD symptoms to self-harm behaviours: a systematic PRISMA review.

Authors:  Clare S Allely
Journal:  BMC Psychiatry       Date:  2014-05-07       Impact factor: 3.630
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.